Court Rules Delta-8 THC from Legal Hemp is Not a Controlled Substance
Court Rules Delta-8 THC from Legal Hemp is Not a Controlled Substance A U.S. Court of Appeals for the Ninth Circuit has ruled that Delta-8
One of the most significant aspects of the Cannabis Act and Regulations is the introduction of a Cannabis Drug License, which will help pave the way for companies looking to develop prescription cannabis-based medications.
This license gives companies the ability to produce and sell prescription drugs containing cannabis. Its inclusion in the Act could turn out to be especially beneficial for consumers, as while medical cannabis isn’t currently covered by insurance, the Act requires that cannabis medicines be given drug-identification numbers, which will provide them with coverage. The first step for companies with the goal of making advancements in cannabis-based drugs is obtaining this license. One important stipulation is that applicants must currently hold a Drug Establishment License (DEL) under Section C.01A.008 of the Food and Drug Regulations, which is required for the manufacturing of pharmaceuticals in general.*Full license requirements have not yet been published, but they are expected to resemble those of a Dealer’s License under the Narcotic Control Regulations.
*Full license requirements have not yet been published, but they are expected to resemble those of a Dealer’s License under the Narcotic Control Regulations.
Court Rules Delta-8 THC from Legal Hemp is Not a Controlled Substance A U.S. Court of Appeals for the Ninth Circuit has ruled that Delta-8
This fall, Health Canada is anticipating sharing a policy consultation document about health products containing (CBD). Get a head start with detailed insights into these regulatory changes.
Canada’s cannabis rules are always changing, and staying up-to-date with these changes is crucial for businesses operating in this space. Recently, Health Canada proposed amendments
Latest Proposed Cannabis Amendments by Health Canada in 2024 Health Canada has proposed a series of regulatory amendments aimed at streamlining various requirements related to
Subscribe To Our Newsletter
Get Latest Industry News and Updates